# Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)

> **NCT01647906** · — · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 277 (actual)

## Conditions studied

- Fecal Incontinence

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01647906
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05-31
- **Primary completion:** 2018-09-15
- **Final completion:** 2018-09-15
- **Target enrollment:** 277 (ACTUAL)
- **Last updated:** 2019-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01647906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01647906, "Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01647906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*